How I evaluate lesions for CT-guided lung biopsy
14 Sep 2018
CT-guided percutaneous lung biopsy is a pivotal test in lung cancer diagnosis. This webinar video outlined the ambulatory lung biopsy pathway. In addition, it focused approaches to lung biopsy, including complex lung biopsy in patients with poor lung function & repeat biopsy in patients with disease progression.
Educational Aims:
• Understand the benefits & advantages of an ambulatory, early discharge lung biopsy pathway versus conventional UK practice
• Understand the pivotal role percutaneous lung biopsy plays in the current management of lung cancer, in particular the importance of genomic tissue analysis & repeat biopsy in cancer progression.
1 CPD credit.
Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate. You must login to watch the video and receive CPD.
Educational Aims:
• Understand the benefits & advantages of an ambulatory, early discharge lung biopsy pathway versus conventional UK practice
• Understand the pivotal role percutaneous lung biopsy plays in the current management of lung cancer, in particular the importance of genomic tissue analysis & repeat biopsy in cancer progression.
1 CPD credit.
Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate. You must login to watch the video and receive CPD.
Duration:67 mins
Speaker info
Dr Sam Hare
Dr Sam Hare is a consultant chest radiologist at Barnet Hospital, which is part of the Royal Free London NHS Foundation Trust. He is also one of the lead radiologists for the London Cancer lung pathway board, responsible for improving regional lung cancer outcomes and patient experience. Dr Hare’s technical lung biopsy expertise has been acknowledged as providing earlier lung cancer diagnosis in a wider range of patients. The novel ambulatory lung biopsy service was awarded the inaugural NHS Innovation Challenge Prize for Cancer Care in 2016 in addition to the 2016 BMJ Award for Cancer Care Team of the Year (sponsored by Macmillan Cancer) & the 2016 HSJ Award for Acute Sector Innovation. Sam is currently focused on leading wider NHS adoption of ‘ambulatory lung biopsy’ and is working closely with NHS England to achieve this. As part of this ambition, he has established a national lung biopsy education course (POBAS) that will train clinicians from other hospitals to use the innovative technique. For more details please visit www.POBAS.co.uk.